Regulatory
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Search
Who we are
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
NCF International
Regulatory
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Home
R&D
Page 7
R&D
Haemophilia A: rurioctocog alfa pegol recommended by CHMP
14 December 2017
Positive results of phase 2 trial on nivolumab/ipilimumab Combo in SCLC
18 October 2017
Negative topline results of intepirdine phase 3 MINDSET trial in Alzheimer’s...
18 October 2017
Alzheimer’s disease: trigriluzole phase 2 trial in collaboration with ADCS
18 October 2017
NBTXR3 will be tested in combination with immune checkpoints inhibitors
18 October 2017
A monoclonal antibody to treat atopic dermatitis
18 October 2017
Four active substance together against HIV infection
18 October 2017
Gene editing. The first recommendations on allowed use
18 October 2017
Neurodegenerative diseases. The role of dopaminergic neurons
18 October 2017
Good results for a phase I/II head and neck cancer trial
14 June 2017
1
...
6
7
8
...
18
Page 7 of 18
Newsstand
NCF International n.2 - 2026
NCF International n.1 - 2026
NCF International n.2 - 2025
Newsstand